首页> 外国专利> 'compound, use of this or a pharmacologically acceptable salt, ester or other derivative thereof, medication, preventive or therapeutic agents for asthma and / or bronchitis, for rhinitis, for allergic disease, and for urinary incontinence, and, prevention processes or treatment of asthma and / or bronchitis, rhinitis, allergic disease, and urinary incontinence. '

'compound, use of this or a pharmacologically acceptable salt, ester or other derivative thereof, medication, preventive or therapeutic agents for asthma and / or bronchitis, for rhinitis, for allergic disease, and for urinary incontinence, and, prevention processes or treatment of asthma and / or bronchitis, rhinitis, allergic disease, and urinary incontinence. '

机译:“该化合物或其药理学上可接受的盐,酯或其他衍生物的用途,用于哮喘和/或支气管炎,鼻炎,过敏性疾病和尿失禁的药物,预防或治疗剂,以及预防或治疗哮喘和/或支气管炎,鼻炎,过敏性疾病和尿失禁。”

摘要

"COMPOUND, USE OF THIS OR A PHARMACOLOGICALLY ACCEPTABLE SALT, IS EITHER OR OTHER DERIVATIVE FROM THE SAME, MEDICINAL PRODUCTS, PREVENTIVE OR THERAPEUTIC AGENTS FOR ASTHMA AND / OR BRONCHITIS, FOR RHINITIS, FOR ALLERGIC DISEASE, AND FOR URINARY PROCEDURE, OR URINARY PROCEDURE, AND URINARY PROCEDURE, OR URINARY PROCEDURE, OR URINARY PROCEDURE, OR URINARY PROCEDURE, OR URINARY PROCEDURE, OR URINARY PROCEDURE, OR URINARY PROTECTION, OR URINARY PROCEDURE, AND URINARY PROCEDURE, OR URINARY PROTECTION, OR URINARY PROCEDURE. TREATMENT OF ASTHMA AND / OR BRONCHITIS, RHINITIS, ALLERGIC DISEASE, AND URINARY INCONTINENCE "[Object] Provide compounds having selective antagonistic activity against NK ~ 2 ~ receptor. [Medium for resolving the object] A compound of formula (I), a pharmaceutically acceptable salt or derivative thereof: {R¹: optionally substituted cycloalkyl, or optionally substituted heterocyclic group; R² optionally substituted aryl, or optionally substituted heteroaryl; A: methylene, carbonyl or sulfonyl; B: single bond, alkylene or alkenylene; D: oxygen atom or sulfur atom; G: alkylene or alkenylene; L - -N (R³) - or -C (R ^ 4 ^) (R ^ 5 ^) -, [R³: optionally substituted aryl or optionally substituted heteroaryl; R 4: H, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted cycloalkyl or optionally substituted saturated heterocyclic group; R ^ 5 ^ alkyl optionally substituted with amino, amino, optionally substituted acylamino, OH, optionally substituted hydroxyalkyl, alkoxy or -CO-R ^ 6 ^ (R ^ 6 ^: alkyl, alkoxy or amine residue); or R ^ 4 ^ together with R ^ 5 ^: cycloalkane ring, cycloalkene ring, saturated heterocyclic ring]; R 7: alkyl; Z: two hydrogen atoms or one oxygen atom; n: 0, 1 or 2}.
机译:“化合物,本药或药理学上可接受的盐的使用,是源自哮喘,气喘,支气管炎,鼻炎,过敏性疾病,泌尿过程的同一,药物,预防或治疗剂的衍生物,以及泌尿过程,或泌尿过程,或泌尿过程,或泌尿过程,或泌尿过程,或泌尿过程,或泌尿保护,或泌尿过程,以及泌尿过程,或泌尿保护,或泌尿过程,或尿/过程。或“支气管炎,鼻炎,过敏性疾病和尿失禁” [目的]提供对NK〜2〜受体具有选择性拮抗活性的化合物。 [用于解决目的的介质]式(I)的化合物,其药学上可接受的盐或衍生物:[R 1:任选取代的环烷基或任选取代的杂环基; R 2任选取代的芳基,或任选取代的杂芳基; A:亚甲基,羰基或磺酰基; B:单键,亚烷基或亚烯基; D:氧原子或硫原子; G:亚烷基或亚烯基; L--N(R 3)-或-C(R ^ 4 ^)(R ^ 5 ^)-,[R 3:任选取代的芳基或任选取代的杂芳基; R 4:H,任选取代的芳基,任选取代的杂芳基,任选取代的环烷基或任选取代的饱和杂环基; R ^ 5 ^烷基任选地被氨基,氨基,任选取代的酰基氨基,OH,任选取代的羟烷基,烷氧基或-CO-R ^ 6 ^取代(R ^ 6 ^:烷基,烷氧基或胺残基);或R ^ 4 ^与R ^ 5 ^一起:环烷环,环烯环,饱和杂环]; R 7:烷基; Z:两个氢原子或一个氧原子; n:0、1或2}。

著录项

  • 公开/公告号BR9815348A

    专利类型

  • 公开/公告日2000-10-17

    原文格式PDF

  • 申请/专利权人 SANKYO COMPANY LIMITED;

    申请/专利号BR19989815348

  • 发明设计人 TAKAHIDE NISHI;TAKESHI YAMAGUCHI;

    申请日1998-12-04

  • 分类号C07D265/30;C07D265/32;C07D413/14;C07D417/14;C07D401/06;C07D495/10;C07D491/107;C07D498/10;A61K31/535;A61K31/55;A61K31/435;A61K31/445;A61K31/495;A61K31/54;

  • 国家 BR

  • 入库时间 2022-08-22 01:57:07

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号